{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-029778","form_type":"8-K","ticker":"LIXT","cik":"0001335105","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2025-12-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.180041+00:00","generated_at":"2026-05-16T11:53:17.336248+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lixte exchanges 2,700 Series C preferred for 700K common shares and 20% of Liora subsidiary","bullets":["Orbit Capital Inc. exchanged 2,700 Series C Preferred shares for 700,000 Lixte common shares and 200 ordinary shares of Liora (20% of Liora).","Upon closing, all Series C Preferred shares were cancelled and no longer outstanding.","Lixte retained 800 ordinary shares of Liora after the exchange.","Transaction was exempt from registration under Section 4(a)(2) and Regulation D."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-029778","json":"https://secwatch.observer/filing/0001493152-25-029778.json","markdown":"https://secwatch.observer/filing/0001493152-25-029778.md","text":"https://secwatch.observer/filing/0001493152-25-029778.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000149315225029778/0001493152-25-029778-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000149315225029778/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:53:17.336248+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}